Date Filed | Type | Description |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2022 |
4
| MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns:
| Granted 18,000 options to buy
@ $0.54, valued at
$9.7k
|
|
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2022 |
3
| MATHIESEN JEFFREY S (Director) has filed a Form 3 on Healthcare Triangle, Inc. |
02/18/2022 |
4
| MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns:
| Granted 8,011 shares
@ $0 |
|
12/20/2021 |
4
| MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.
Txns:
| Bought 3,000 shares
@ $5.3098, valued at
$15.9k
|
|
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Panbela Therapeutics, Inc.
Txns:
| Granted 2,875 shares
@ $0 |
|
06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns:
| Exercised 34,020 options to buy
@ $0.035, valued at
$1.2k
|
|
06/16/2020 |
3/A
| MATHIESEN JEFFREY S (Director) has filed a Form 3/A on HELIUS MEDICAL TECHNOLOGIES, INC. |
06/12/2020 |
3
| MATHIESEN JEFFREY S (Director) has filed a Form 3 on HELIUS MEDICAL TECHNOLOGIES, INC. |
06/04/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns:
| Granted 22,371 shares
@ $0 Granted 23,725 options to buy
@ $1.48, valued at
$35.1k
|
|
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/07/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns:
| Granted 100,000 options to buy
@ $2.14, valued at
$214k
|
|
06/06/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns:
| Granted 14,006 shares
@ $0 Granted 14,995 options to buy
@ $2.38, valued at
$35.7k
|
|
05/23/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Sun BioPharma, Inc.
Txns:
| Granted 27,000 options to buy
@ $2.95, valued at
$79.7k
Granted 6,800 options to buy
@ $2.95, valued at
$20.1k
|
|
05/15/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns:
| Granted 45,605 options to buy
@ $2.38, valued at
$108.5k
|
|
02/22/2018 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Sun BioPharma, Inc.
Txns:
| Bought 3,000 shares
@ $0 Bought 3,000 warrants
@ $5, valued at
$15k
|
|
01/30/2018 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns:
| Granted 48,000 options to buy
@ $10.1, valued at
$484.8k
|
|
08/16/2017 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns:
| Exercised 3,207 options to buy
@ $3.59, valued at
$11.5k
|
|
08/15/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/11/2017 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc.
Txns:
| Exercised 3,000 options to buy
@ $3.59, valued at
$10.8k
|
|
08/04/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/08/2016 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc. |
08/04/2016 |
3
| MATHIESEN JEFFREY S (CFO) has filed a Form 3 on Gemphire Therapeutics Inc. |
09/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |